Innovative diagnosticsand therapeuticsfor metabolic disease
Back to News list

NUTRINOSTICS FOR THE EARLY DIAGNOSIS AND PREVENTION OF NASH

NUTRINOSTICS FOR THE EARLY DIAGNOSIS AND PREVENTION OF NASH

  18 02 2020

CellMade, a biopharmaceutical company actively engaged in the discovery of biomarkers and the development of medical nutrition products for the early diagnosis and preventive treatment of metabolic and inflammatory disease, discloses its combined systems biology and translational research strategy.